Osteotech, Inc. (Osteotech) has entered into a multi-year tissue supply agreement with Community Tissue Services or CTS, with an initial term spanning 10 years. This new agreement replaces an existing contract between the two companies that would have expired in 2011.

Under the terms of the agreement, Osteotech noted that CTS will supply the company with a specific number of whole donors and cortical shafts on a monthly basis based upon periodic forecast requirements and available tissue supply. This new agreement expires in December 2019 and includes one 5-year renewal term and subsequent 2-year renewal terms, subject to six month cancellation clauses.

Osteotech is a provider of biologic solutions for regenerative medicine to support surgeons and their patients through the development of therapy-driven products.